Calreticulin couples with immune checkpoints in pancreatic cancer
Abstract Although immune checkpoint blockade is considered to be the dominant approach in future cancer immunotherapy, whether it will apply to pancreatic cancer remains largely unknown. To address this issue, pancreatic cancer–associated datasets were individually collected by Gene Expression Profi...
Main Authors: | Xing Huang, Tianyu Tang, Xun Wang, Xueli Bai, Tingbo Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-03-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctm2.10 |
Similar Items
-
Calreticulin—Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients
by: Michal Kielbik, et al.
Published: (2021-01-01) -
From Immunogenic Cell Death to Immunogenic Modulation: Select Chemotherapy Regimens Induce a Spectrum of Immune-Enhancing Activities in the Tumor Microenvironment
by: Kellsye P. Fabian, et al.
Published: (2021-08-01) -
Contribution of annexin A1 to anticancer immunosurveillance
by: Elisa Elena Baracco, et al.
Published: (2019-11-01) -
Integrins and ERp57 Coordinate to Regulate Cell Surface Calreticulin in Immunogenic Cell Death
by: Chi-Chao Liu, et al.
Published: (2019-05-01) -
Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors
by: Qi J, et al.
Published: (2021-02-01)